Chief Executive Officer
Current
Jun 2023 - Present
AeroLeads people directory · profile
Jacob Pade Ramsøe Jacobsen Email & Phone Number
Chief Executive Officer at Evecxia Therapeutics
at
Evecxia Therapeutics, Inc.
2 work emails found
@evecxia.com
LinkedIn matched
✓ Verified May 2026
4 data sources
Profile completeness 100%
Current company
Role
Chief Executive Officer at Evecxia Therapeutics
Location
Durham, North Carolina, United States
Who is Jacob Pade Ramsøe Jacobsen? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Jacob Pade Ramsøe Jacobsen is listed as Chief Executive Officer at Evecxia Therapeutics at Evecxia Therapeutics, Inc., based in Durham, North Carolina, United States. AeroLeads shows a work email signal at evecxia.com and a matched LinkedIn profile for Jacob Pade Ramsøe Jacobsen.
Jacob Pade Ramsøe Jacobsen previously worked as Chief Executive Officer at Evecxia Therapeutics, Inc. and Chief Scientific Officer at Evecxia Therapeutics, Inc.. Jacob Pade Ramsøe Jacobsen holds Master Of Science (Ms), Human Biology from Københavns Universitet - University Of Copenhagen.
Company email context
Email format at Evecxia Therapeutics, Inc.
This section adds company-level context without repeating Jacob Pade Ramsøe Jacobsen's masked contact details.
{first}@evecxia.com
89% confidence
AeroLeads found 2 current-domain work email signals for Jacob Pade Ramsøe Jacobsen. Compare company email patterns before reaching out.
Profile bio
About Jacob Pade Ramsøe Jacobsen
Neuropharmacologist committed to bettering the lives of people with mental disorders.
Listed skills include In Situ Hybridization, Cognition, Neuropharmacology, Western Blotting, and 27 others.
Current workplace
Jacob Pade Ramsøe Jacobsen's current company
Company context helps verify the profile and gives searchers a useful next step.
8 roles · 26 years
Jacob Pade Ramsøe Jacobsen work experience
A career timeline built from the work history available for this profile.
Chief Scientific Officer
There are 9m drug-treated depression patients in the US. Only one-third respond adequately to first-line antidepressant (e.g. Prozac). Next-line antidepressants are limited by, modest efficacy, poor safety, and/or, high burden for the patient. Evecxia is developing an antidepressant, EVX-101, that will be used as add-on, augmentation treatment, on top of.
Jan 2016 - Jun 2023
Adjunct Assistant Professor
Clinical grant collaboration to determine key pharmacodynamics parameters for putative novel antidepressant compound, with the long-term aim of producing a drug candidate for human clinical trials.
Mar 2015 - Jun 2023
Scientist
I researched a novel antidepressant augmentation concept. I worked towards translating this research, from idea and animal data, into an FDA-approved drug.
May 2009 - Aug 2019
Post Doc, Dept In Vivo Pharmacology
Neurosearch
NeuroSearch was a Danish CNS focused biotech. At NeuroSearch my main charge was to drive the characterization of a SK3 channel conditional knock-out mouse line. The aim of the project was to inform about the drug-target potential of SK3 in mouse behavioral/neurochemical models, potential detrimental consequences of SK3 modulation and the mechanism of.
Jun 2006 - Apr 2008
Post-Doctoral Associate, Dept Pharmacology
Pursued research into the interplay between kappa opioids, drug-abuse and stress.
Feb 2005 - Jan 2006
Post-Doc, Dept Neurochemistry
Following graduating with my industrial PhD, I stayed on at Lundbeck for half a year at Lundbeck. Main charges were to set-up mouse microdialysis and to establish a HPLC-UV assay for chiral separation of the amino acid serine. Both goals were met. Using these technologies, I evaluated the D-serine releasing properties of a couple of tool compounds.
Jul 2004 - Jan 2005
Research Fellow/Phd Student
2000 - 2005
~5 yrs
3 education records
Jacob Pade Ramsøe Jacobsen education
Master Of Science (Ms), Human Biology
Københavns Universitet - University Of Copenhagen
Doctor Of Philosophy (Phd), Neuropharmacology
Københavns Universitet - University Of Copenhagen
Bachelor'S Degree, Biology, General
Københavns Universitet - University Of Copenhagen
FAQ
Frequently asked questions about Jacob Pade Ramsøe Jacobsen
Quick answers generated from the profile data available on this page.
What company does Jacob Pade Ramsøe Jacobsen work for?
Jacob Pade Ramsøe Jacobsen works for Evecxia Therapeutics, Inc..
What is Jacob Pade Ramsøe Jacobsen's role at Evecxia Therapeutics, Inc.?
Jacob Pade Ramsøe Jacobsen is listed as Chief Executive Officer at Evecxia Therapeutics at Evecxia Therapeutics, Inc..
What is Jacob Pade Ramsøe Jacobsen's email address?
AeroLeads has found 2 work email signals at @evecxia.com for Jacob Pade Ramsøe Jacobsen at Evecxia Therapeutics, Inc..
Where is Jacob Pade Ramsøe Jacobsen based?
Jacob Pade Ramsøe Jacobsen is based in Durham, North Carolina, United States while working with Evecxia Therapeutics, Inc..
What companies has Jacob Pade Ramsøe Jacobsen worked for?
Jacob Pade Ramsøe Jacobsen has worked for Evecxia Therapeutics, Inc., Duke-Nus Medical School, Duke University Medical Center, Neurosearch, and University Of Washington.
How can I contact Jacob Pade Ramsøe Jacobsen?
You can use AeroLeads to view verified contact signals for Jacob Pade Ramsøe Jacobsen at Evecxia Therapeutics, Inc., including work email, phone, and LinkedIn data when available.
What schools did Jacob Pade Ramsøe Jacobsen attend?
Jacob Pade Ramsøe Jacobsen holds Master Of Science (Ms), Human Biology from Københavns Universitet - University Of Copenhagen.
What skills is Jacob Pade Ramsøe Jacobsen known for?
Jacob Pade Ramsøe Jacobsen is listed with skills including In Situ Hybridization, Cognition, Neuropharmacology, Western Blotting, Neuroscience, Animal Models, Psychiatry, and Biomarkers.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial